Patents by Inventor Greta Maria Paola GIORDANO ATTIANESE

Greta Maria Paola GIORDANO ATTIANESE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CAR-T CELL THERAPY TARGETING NGCGM3
    Publication number: 20230141511
    Abstract: The invention relates to chimeric antigen receptors (CARs) targeting a cancer-associated antigen and their use for treatment of a tumor or cancer. In particular, the invention provides compositions and methods for treating diseases associated with the antigen NGcGM3. The invention also relates to CARs specific to NGcGM3, vectors encoding the same, and recombinant T cells comprising the CARs of the present invention. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an antigen binding domain that binds to NGcGM3.
    Type: Application
    Filed: December 18, 2020
    Publication date: May 11, 2023
    Applicants: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD, UNIVERSITY OF LAUSANNE, CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
    Inventors: George COUKOS, Melita IRVING, Greta Maria Paola Giordano ATTIANESE
  • HETERODIMERIC INACTIVATABLE CHIMERIC ANTIGEN RECEPTORS
    Publication number: 20210113615
    Abstract: The invention relates to heterodimeric inactivatable chimeric antigen receptors (CARs) and their use for treatment.
    Type: Application
    Filed: April 12, 2019
    Publication date: April 22, 2021
    Applicants: Ludwig Institute for Cancer Research Ltd., École Polytechnique Fédérale de Lausanne
    Inventors: George COUKOS, Melita IRVING, Bruno CORREIA, Pablo GAINZA-CIRAUQUI, Greta Maria Paola GIORDANO ATTIANESE